Effects of Seroquel XR (Quetiapine Fumarate Extended-Release) on Sleep Architecture in Patients With Major Depressive Disorder.

Trial Profile

Effects of Seroquel XR (Quetiapine Fumarate Extended-Release) on Sleep Architecture in Patients With Major Depressive Disorder.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 10 Aug 2015

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Ewha Womans University
  • Most Recent Events

    • 08 Aug 2015 Status is changed from recruiting to withdrawn prior to enrollment as reported by ClinicalTrials.gov record
    • 06 Jun 2012 Planned number of patients changed from 30 to 45 as reported ClinicalTrials.gov.
    • 06 Jun 2012 Actual initiation date (Mar 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top